Literature DB >> 29533668

Biomimetic Targeting of Nanoparticles to Immune Cell Subsets via Cognate Antigen Interactions.

Brian T Luk1, Yao Jiang1, Jonathan A Copp1, Che-Ming J Hu2, Nishta Krishnan1, Weiwei Gao1, Shulin Li3, Ronnie H Fang1, Liangfang Zhang1.   

Abstract

Within the body, cellular recognition is mediated in large part by receptor-ligand interactions that result from the surface marker expression of the participant cells. In the case of immune cells, these interactions can be highly specific, enabling them to carry out their protective functions in fighting off infection and malignancy. In this work, we demonstrate the biomimetic targeting of antigen-specific immune cell populations by using nanoparticles functionalized with natural membrane derived from cells expressing the cognate antigen. Using red blood cell (RBC)-specific B cells as a model target, it is shown that RBC membrane-coated nanoparticles exhibit enhanced affinity compared with control nanoparticles. The concept is further demonstrated using murine models of alloimmunity and autoimmunity, where B cells elicited against RBCs can be positively labeled using the biomimetic nanoparticles. This strategy for antigen-specific immune cell targeting may have utility for the detection and treatment of various autoimmune conditions, and it may additionally have implications for the prevention of immune cell malignancies.

Entities:  

Keywords:  B cell; autoimmune disease; biointerfacing; biomimetic nanotechnology; lymphoma; membrane-coated nanoparticle

Mesh:

Year:  2018        PMID: 29533668      PMCID: PMC6123265          DOI: 10.1021/acs.molpharmaceut.8b00074

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  42 in total

1.  Autoimmunity and lymphoma: tribulations of B cells.

Authors:  I R Mackay; N R Rose
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

Review 2.  The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy.

Authors:  Tennyson L Doane; Clemens Burda
Journal:  Chem Soc Rev       Date:  2012-01-27       Impact factor: 54.564

Review 3.  B cells as therapeutic targets in SLE.

Authors:  Iñaki Sanz; F Eun-Hyung Lee
Journal:  Nat Rev Rheumatol       Date:  2010-06       Impact factor: 20.543

Review 4.  Emerging implications of nanotechnology on cancer diagnostics and therapeutics.

Authors:  Alex G Cuenca; Huabei Jiang; Steven N Hochwald; Matthew Delano; William G Cance; Stephen R Grobmyer
Journal:  Cancer       Date:  2006-08-01       Impact factor: 6.860

5.  Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies.

Authors:  Che-Ming J Hu; Ronnie H Fang; Brian T Luk; Liangfang Zhang
Journal:  Nanoscale       Date:  2013-11-26       Impact factor: 7.790

Review 6.  Nanoparticle delivery of cancer drugs.

Authors:  Andrew Z Wang; Robert Langer; Omid C Farokhzad
Journal:  Annu Rev Med       Date:  2011-09-01       Impact factor: 13.739

7.  Evolution and Clinical Translation of Drug Delivery Nanomaterials.

Authors:  Shabir Hassan; Gyan Prakash; Aycabal Ozturk; Saghi Saghazadeh; Mohammad Farhan Sohail; Jungmok Seo; Mehmet Dockmeci; Yu Shrike Zhang; Ali Khademhosseini
Journal:  Nano Today       Date:  2017-08-02       Impact factor: 20.722

Review 8.  Cancer nanomedicine: progress, challenges and opportunities.

Authors:  Jinjun Shi; Philip W Kantoff; Richard Wooster; Omid C Farokhzad
Journal:  Nat Rev Cancer       Date:  2016-11-11       Impact factor: 60.716

9.  CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia.

Authors:  Amina Mqadmi; Xiaoying Zheng; Karina Yazdanbakhsh
Journal:  Blood       Date:  2005-01-06       Impact factor: 22.113

Review 10.  Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery.

Authors:  B Mishra; Bhavesh B Patel; Sanjay Tiwari
Journal:  Nanomedicine       Date:  2009-05-15       Impact factor: 5.307

View more
  10 in total

Review 1.  Engineering biological interactions on the nanoscale.

Authors:  Yao Jiang; Sanam Chekuri; Ronnie H Fang; Liangfang Zhang
Journal:  Curr Opin Biotechnol       Date:  2018-11-01       Impact factor: 9.740

Review 2.  Engineering at the nano-bio interface: harnessing the protein corona towards nanoparticle design and function.

Authors:  Rebecca L Pinals; Linda Chio; Francis Ledesma; Markita P Landry
Journal:  Analyst       Date:  2020-07-01       Impact factor: 4.616

Review 3.  Latest Advances in Biomimetic Cell Membrane-Coated and Membrane-Derived Nanovectors for Biomedical Applications.

Authors:  Riccardo Rampado; Paolo Caliceti; Marco Agostini
Journal:  Nanomaterials (Basel)       Date:  2022-05-02       Impact factor: 5.719

Review 4.  Bioinspired membrane-based nanomodulators for immunotherapy of autoimmune and infectious diseases.

Authors:  Yesi Shi; Hongyan Qian; Peishi Rao; Dan Mu; Yuan Liu; Gang Liu; Zhongning Lin
Journal:  Acta Pharm Sin B       Date:  2021-10-01       Impact factor: 14.903

5.  Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy.

Authors:  Xi Cao; Tingfei Tan; Dongchun Zhu; Haixia Yu; Yaru Liu; Haiyun Zhou; Yong Jin; Quan Xia
Journal:  Int J Nanomedicine       Date:  2020-03-19

Review 6.  Nanoparticle Platforms for Antigen-Specific Immune Tolerance.

Authors:  Edward B Thorp; Christian Boada; Clarens Jarbath; Xunrong Luo
Journal:  Front Immunol       Date:  2020-05-20       Impact factor: 7.561

Review 7.  Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy.

Authors:  Jia Zhuang; Maya Holay; Joon Ho Park; Ronnie H Fang; Jie Zhang; Liangfang Zhang
Journal:  Theranostics       Date:  2019-10-15       Impact factor: 11.556

8.  CD4+ T cell-mimicking nanoparticles encapsulating DIABLO/SMAC mimetics broadly neutralize HIV-1 and selectively kill HIV-1-infected cells.

Authors:  Grant R Campbell; Jia Zhuang; Gang Zhang; Igor Landa; Luke J Kubiatowicz; Diana Dehaini; Ronnie H Fang; Liangfang Zhang; Stephen A Spector
Journal:  Theranostics       Date:  2021-08-25       Impact factor: 11.600

9.  Optimization of critical parameters for coating of polymeric nanoparticles with plasma membrane vesicles by sonication.

Authors:  Feipeng Yang; Maleen H Cabe; Sean D Ogle; Veronica Sanchez; Kelly A Langert
Journal:  Sci Rep       Date:  2021-12-14       Impact factor: 4.996

10.  CD4+ T Cell-Mimicking Nanoparticles Broadly Neutralize HIV-1 and Suppress Viral Replication through Autophagy.

Authors:  Gang Zhang; Grant R Campbell; Qiangzhe Zhang; Erin Maule; Jonathan Hanna; Weiwei Gao; Liangfang Zhang; Stephen A Spector
Journal:  mBio       Date:  2020-09-15       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.